Diamond-Blackfan anemia epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{Diamond-Blackfan anemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References=...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diamond-Blackfan anemia}} | {{Diamond-Blackfan anemia}} | ||
==Overview== | |||
==Diamond-Blackfan anemia epidemiology and demographics== | |||
*'''Incidence''' | |||
Incidence of Classical Diamond-Blackfan anemia (DBA) is about seven per million live births per year. Thus in the United States, with 4 million live births per year, each year approximately 25-35 new patients will be diagnosed.<ref name="pmid18671700">{{cite journal |vauthors=Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM |title=Diagnosing and treating Diamond Blackfan anemia: results of an international clinical consensus conference |journal=Br. J. Haematol. |volume=142 |issue=6 |pages=859–76 |date=September 2008 |pmid=18671700 |pmc=2654478 |doi=10.1111/j.1365-2141.2008.07269.x |url=}}</ref> | |||
*'''Prevalence of DBA''' | |||
It is approximately 5000 cases worldwide. | |||
*'''Age''' | |||
DBA is usually first diagnosed in infancy. The average age of presenting with anemia is two months and the average age of diagnosis with DBA is 3-4 months. | |||
*Race | |||
There is no racial predilection to DBA. | |||
*'''Gender''' | |||
DBA affects men and women equally.<ref name="pmid10541318">{{cite journal |vauthors=Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, Lambiliotte A, Kohne E, Souillet G, Eber S, Stephan JL, Girot R, Bordigoni P, Cornu G, Blanche S, Guillard JM, Mohandas N, Tchernia G |title=Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI) |journal=Pediatr. Res. |volume=46 |issue=5 |pages=553–61 |date=November 1999 |pmid=10541318 |doi=10.1203/00006450-199911000-00011 |url=}}</ref> | |||
*'''Region''' | |||
The majority of [disease name] cases are reported in [geographical region]. | |||
[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | |||
'''*Developed Countries''' | |||
==References== | ==References== | ||
Revision as of 22:42, 7 August 2020
|
Diamond-Blackfan anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diamond-Blackfan anemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diamond-Blackfan anemia epidemiology and demographics |
|
FDA on Diamond-Blackfan anemia epidemiology and demographics |
|
CDC on Diamond-Blackfan anemia epidemiology and demographics |
|
Diamond-Blackfan anemia epidemiology and demographics in the news |
|
Blogs on Diamond-Blackfan anemia epidemiology and demographics |
|
Risk calculators and risk factors for Diamond-Blackfan anemia epidemiology and demographics |
Overview
Diamond-Blackfan anemia epidemiology and demographics
- Incidence
Incidence of Classical Diamond-Blackfan anemia (DBA) is about seven per million live births per year. Thus in the United States, with 4 million live births per year, each year approximately 25-35 new patients will be diagnosed.[1]
- Prevalence of DBA
It is approximately 5000 cases worldwide.
- Age
DBA is usually first diagnosed in infancy. The average age of presenting with anemia is two months and the average age of diagnosis with DBA is 3-4 months.
- Race
There is no racial predilection to DBA.
- Gender
DBA affects men and women equally.[2]
- Region
The majority of [disease name] cases are reported in [geographical region]. [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. *Developed Countries
References
- ↑ Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM (September 2008). "Diagnosing and treating Diamond Blackfan anemia: results of an international clinical consensus conference". Br. J. Haematol. 142 (6): 859–76. doi:10.1111/j.1365-2141.2008.07269.x. PMC 2654478. PMID 18671700.
- ↑ Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, Lambiliotte A, Kohne E, Souillet G, Eber S, Stephan JL, Girot R, Bordigoni P, Cornu G, Blanche S, Guillard JM, Mohandas N, Tchernia G (November 1999). "Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI)". Pediatr. Res. 46 (5): 553–61. doi:10.1203/00006450-199911000-00011. PMID 10541318.